Cargando…

Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies

A new treatment strategy is needed, as the efficacy of triple therapy containing clarithromycin—the current standard treatment for Helicobacter pylori infection—is declining. Increasing antibiotic resistance of H. pylori is the most significant factor contributing to eradication failure. Thus, selec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ju Yup, Park, Kyung Sik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187483/ https://www.ncbi.nlm.nih.gov/pubmed/28070184 http://dx.doi.org/10.1155/2016/9086581

Ejemplares similares

The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012
por: Kuo, Chao-Hung, et al.
Publicado: (2012)

Adapted first-line treatment of Helicobacter pylori infection in Algerian children
por: Moubri, Mostefa, et al.
Publicado: (2019)

Recent progress in Helicobacter pylori treatment
por: Hu, Yi, et al.
Publicado: (2020)

The status and progress of first-line treatment against Helicobacter pylori infection: a review
por: Liu, Caiqi, et al.
Publicado: (2021)

Diagnosis of Helicobacter pylori Infection and Recent Advances
por: Yang, Hang, et al.
Publicado: (2021)

Which should be the first-line treatment for Helicobacter pylori in Colombia? A lesson from a recent study
por: Pellicano, Rinaldo
Publicado: (2019)

Efficacy of Sequential Therapy as the First-Line Treatment in the Eradication of Helicobacter pylori
por: Tamene, Yonas, et al.
Publicado: (2023)

Can Aminoglycosides Be Used as a New Treatment for Helicobacter pylori? In vitro Activity of Recently Isolated Helicobacter pylori
por: Lee, Kyoung Hwa, et al.
Publicado: (2019)

Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori
por: Tariq, Hassan, et al.
Publicado: (2020)

Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
por: Chang, Ji Young, et al.
Publicado: (2017)

Update on the first-line treatment of Helicobacter pylori infection in areas with high and low clarithromycin resistances
por: Shih, Chih-An, et al.
Publicado: (2022)

Additive Effect of Pronase on the Eradication Rate of First-Line Therapy for Helicobacter pylori Infection
por: Bang, Chang Seok, et al.
Publicado: (2015)

Helicobacter pylori Treatment Strategies in Singapore
por: Ang, Tiing Leong, et al.
Publicado: (2021)

Changes in the Treatment Strategies for Helicobacter pylori Infection in Children and Adolescents in Korea
por: Jun, Jin-Su, et al.
Publicado: (2019)

Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea
por: Kim, Beom Jin, et al.
Publicado: (2019)

Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections
por: Ahn, Hyo Jun, et al.
Publicado: (2017)

Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial
por: Lee, Ju Yup, et al.
Publicado: (2016)

Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy
por: Huang, Chih-Chieh, et al.
Publicado: (2017)

Update on the second-line treatment of Helicobacter pylori infection: a narrative review
por: Shih, Chih-An, et al.
Publicado: (2023)

High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea
por: Kwack, WonGun, et al.
Publicado: (2016)

Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradication
por: Kwon, Yong Hwan, et al.
Publicado: (2023)

Dual Therapy Trial Using Esomeprazole and Amoxicillin as Third-line Rescue Therapy for Helicobacter pylori Infection
por: Park, Hyun Kyung, et al.
Publicado: (2011)

Recent advances in Helicobacter pylori eradication
por: Niv, Yaron, et al.
Publicado: (2015)

Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015)

European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain
por: Caldas, María, et al.
Publicado: (2020)

Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection
por: Mascellino, Maria Teresa, et al.
Publicado: (2017)

Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2020
por: Jung, Hye-Kyung, et al.
Publicado: (2021)

Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020
por: Jung, Hye-Kyung, et al.
Publicado: (2021)

Treatment of Pediatric Helicobacter pylori Infection
por: Lai, Hung-Hsiang, et al.
Publicado: (2022)

Second-line rescue treatment of Helicobacter pylori infection: Where are we now?
por: Lin, Te-Fu, et al.
Publicado: (2018)

Strategies used by helicobacter pylori to establish persistent infection
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS
por: RAMZY, Iman, et al.
Publicado: (2016)

Incidence of Infection among Subjects with Helicobacter pylori Seroconversion
por: Kim, Young Jung, et al.
Publicado: (2022)

First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori
por: Zhang, Lingyun, et al.
Publicado: (2019)

Recent Acquisition of Helicobacter pylori by Baka Pygmies
por: Nell, Sandra, et al.
Publicado: (2013)

Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance
por: Cosme, Angel, et al.
Publicado: (2017)

Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
por: Lee, Hyuk, et al.
Publicado: (2017)

Molecular Mechanisms of Antibiotic Resistance and Novel Treatment Strategies for Helicobacter pylori Infections
por: Srisuphanunt, Mayuna, et al.
Publicado: (2023)

The Association between Helicobacter pylori Infection and Body Weight among Children
por: Choi, Jun Sik, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_519pr0lq8fvaljk0tenruffah4